Oncol Nurs Forum:乳腺癌患者存活早期心理困扰较严重

2015-02-21 Jessie 译 MedSci原创

v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);} Normal

心理困扰是癌症患者的常见症状之一,在乳腺癌患者中普遍存在,并伴随多种躯体、心理和社会需求。乳腺癌患者存活时间相对较长,不同的时间段决定患者的心理困扰水平高低。近期,俄亥俄大学的研究者比较了治疗期间、治疗结束、治疗后3个月及治疗后6个月这四个时间点乳腺癌患者的心理困扰水平。
 
该研究共调查了100名乳腺癌患者,均来自一个国家性的综合癌症治疗中心,代表了四个时间点的患者:25名处于治疗期间,25名是治疗结束的患者,25名是治疗3个月后的患者,还有25名是治疗6个月后的患者。应用NCCN建议的心理困扰问卷和38条目的心理困扰问题清单来评估患者自我报告的心理困扰水平及心理困扰的具体来源。心理困扰的评价是从0分(没有困扰)到10分(非常困扰),评分大于等于4分说明存在中度至重度水平的心理困扰。38条目的问题清单包括可能的困扰来源,包括5个分量表:实践,家庭,情感,躯体及精神/信仰方面的问题。
 
被调查的乳腺癌患者总体心理困扰平均得分为4.3SD=3.1,范围为0~10)。从治疗期间至治疗后3个月,患者心理困扰平均分均在4分以上(4.1~5.1分),治疗后6个月,患者的心理困扰水平显著降低(3.6分)。单因素方差分析显示,四个时间点的心理困扰得分的差异具有统计学意义(F[3,96]=5.3P=0.002)。事后检验发现,治疗期间、治疗结束及治疗后3个月这三个时间点的心理困扰水平差异无统计学意义,但治疗后6个月时与之前的三个时间相比,心理困扰水平显著较低(P0.01)。在这四个时间点,患者报告的问题总得分、情绪维度及躯体维度的得分均存在显著差异。
 
该研究结果显示,乳腺癌患者普遍存在心理困扰。在早期存活阶段(从治疗至治疗后3个月),心理困扰水平处于较高水平,但随后心理困扰显著降低。研究者建议,应在早期存活阶段对乳腺癌患者的心理困扰进行筛查,以发现心理困扰的问题来源并进行有针对性的干预。


原始出处:

Lester J, Crosthwaite K, Stout R, Jones RN, Holloman C, Shapiro C, Andersen BL. Women with breast cancer: self-reported distress in early survivorship. Oncol Nurs Forum. 2015 Jan 1;42(1):E17-23. doi: 10.1188/15.ONF.E17-E23.
 
 
本文是MedSci编译,欢迎转载,转载请注明出处,非常感谢!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1744109, encodeId=59861e441093d, content=<a href='/topic/show?id=72105114331' target=_blank style='color:#2F92EE;'>#心理困扰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51143, encryptionId=72105114331, topicName=心理困扰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b33335283413, createdName=般若傻瓜, createdTime=Fri Nov 27 07:08:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864605, encodeId=d95a18646057d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri May 22 03:08:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23708, encodeId=17d023e08fc, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:32:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23687, encodeId=3b7d2368e0c, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:28:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22171, encodeId=9ece221e19a, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b62c1622888, createdName=asd657144091, createdTime=Tue Apr 28 11:09:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570947, encodeId=452515e0947c3, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Mon Feb 23 08:08:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16750, encodeId=56a616e50d6, content=文章好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Feb 23 01:05:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16705, encodeId=a8c816e051c, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:23:00 CST 2015, time=2015-02-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1744109, encodeId=59861e441093d, content=<a href='/topic/show?id=72105114331' target=_blank style='color:#2F92EE;'>#心理困扰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51143, encryptionId=72105114331, topicName=心理困扰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b33335283413, createdName=般若傻瓜, createdTime=Fri Nov 27 07:08:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864605, encodeId=d95a18646057d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri May 22 03:08:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23708, encodeId=17d023e08fc, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:32:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23687, encodeId=3b7d2368e0c, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:28:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22171, encodeId=9ece221e19a, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b62c1622888, createdName=asd657144091, createdTime=Tue Apr 28 11:09:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570947, encodeId=452515e0947c3, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Mon Feb 23 08:08:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16750, encodeId=56a616e50d6, content=文章好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Feb 23 01:05:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16705, encodeId=a8c816e051c, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:23:00 CST 2015, time=2015-02-22, status=1, ipAttribution=)]
    2015-05-22 minlingfeng
  3. [GetPortalCommentsPageByObjectIdResponse(id=1744109, encodeId=59861e441093d, content=<a href='/topic/show?id=72105114331' target=_blank style='color:#2F92EE;'>#心理困扰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51143, encryptionId=72105114331, topicName=心理困扰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b33335283413, createdName=般若傻瓜, createdTime=Fri Nov 27 07:08:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864605, encodeId=d95a18646057d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri May 22 03:08:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23708, encodeId=17d023e08fc, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:32:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23687, encodeId=3b7d2368e0c, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:28:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22171, encodeId=9ece221e19a, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b62c1622888, createdName=asd657144091, createdTime=Tue Apr 28 11:09:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570947, encodeId=452515e0947c3, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Mon Feb 23 08:08:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16750, encodeId=56a616e50d6, content=文章好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Feb 23 01:05:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16705, encodeId=a8c816e051c, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:23:00 CST 2015, time=2015-02-22, status=1, ipAttribution=)]
    2015-05-16 ljjj1053

    很不错学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1744109, encodeId=59861e441093d, content=<a href='/topic/show?id=72105114331' target=_blank style='color:#2F92EE;'>#心理困扰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51143, encryptionId=72105114331, topicName=心理困扰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b33335283413, createdName=般若傻瓜, createdTime=Fri Nov 27 07:08:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864605, encodeId=d95a18646057d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri May 22 03:08:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23708, encodeId=17d023e08fc, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:32:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23687, encodeId=3b7d2368e0c, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:28:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22171, encodeId=9ece221e19a, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b62c1622888, createdName=asd657144091, createdTime=Tue Apr 28 11:09:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570947, encodeId=452515e0947c3, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Mon Feb 23 08:08:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16750, encodeId=56a616e50d6, content=文章好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Feb 23 01:05:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16705, encodeId=a8c816e051c, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:23:00 CST 2015, time=2015-02-22, status=1, ipAttribution=)]
    2015-05-16 ljjj1053

    很不错学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1744109, encodeId=59861e441093d, content=<a href='/topic/show?id=72105114331' target=_blank style='color:#2F92EE;'>#心理困扰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51143, encryptionId=72105114331, topicName=心理困扰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b33335283413, createdName=般若傻瓜, createdTime=Fri Nov 27 07:08:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864605, encodeId=d95a18646057d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri May 22 03:08:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23708, encodeId=17d023e08fc, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:32:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23687, encodeId=3b7d2368e0c, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:28:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22171, encodeId=9ece221e19a, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b62c1622888, createdName=asd657144091, createdTime=Tue Apr 28 11:09:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570947, encodeId=452515e0947c3, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Mon Feb 23 08:08:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16750, encodeId=56a616e50d6, content=文章好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Feb 23 01:05:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16705, encodeId=a8c816e051c, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:23:00 CST 2015, time=2015-02-22, status=1, ipAttribution=)]
    2015-04-28 asd657144091

    很好的文章,学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1744109, encodeId=59861e441093d, content=<a href='/topic/show?id=72105114331' target=_blank style='color:#2F92EE;'>#心理困扰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51143, encryptionId=72105114331, topicName=心理困扰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b33335283413, createdName=般若傻瓜, createdTime=Fri Nov 27 07:08:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864605, encodeId=d95a18646057d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri May 22 03:08:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23708, encodeId=17d023e08fc, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:32:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23687, encodeId=3b7d2368e0c, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:28:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22171, encodeId=9ece221e19a, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b62c1622888, createdName=asd657144091, createdTime=Tue Apr 28 11:09:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570947, encodeId=452515e0947c3, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Mon Feb 23 08:08:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16750, encodeId=56a616e50d6, content=文章好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Feb 23 01:05:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16705, encodeId=a8c816e051c, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:23:00 CST 2015, time=2015-02-22, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1744109, encodeId=59861e441093d, content=<a href='/topic/show?id=72105114331' target=_blank style='color:#2F92EE;'>#心理困扰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51143, encryptionId=72105114331, topicName=心理困扰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b33335283413, createdName=般若傻瓜, createdTime=Fri Nov 27 07:08:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864605, encodeId=d95a18646057d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri May 22 03:08:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23708, encodeId=17d023e08fc, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:32:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23687, encodeId=3b7d2368e0c, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:28:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22171, encodeId=9ece221e19a, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b62c1622888, createdName=asd657144091, createdTime=Tue Apr 28 11:09:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570947, encodeId=452515e0947c3, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Mon Feb 23 08:08:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16750, encodeId=56a616e50d6, content=文章好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Feb 23 01:05:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16705, encodeId=a8c816e051c, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:23:00 CST 2015, time=2015-02-22, status=1, ipAttribution=)]
    2015-02-23 午夜星河

    文章好

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1744109, encodeId=59861e441093d, content=<a href='/topic/show?id=72105114331' target=_blank style='color:#2F92EE;'>#心理困扰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51143, encryptionId=72105114331, topicName=心理困扰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b33335283413, createdName=般若傻瓜, createdTime=Fri Nov 27 07:08:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1864605, encodeId=d95a18646057d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Fri May 22 03:08:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23708, encodeId=17d023e08fc, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:32:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23687, encodeId=3b7d2368e0c, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:28:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22171, encodeId=9ece221e19a, content=很好的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b62c1622888, createdName=asd657144091, createdTime=Tue Apr 28 11:09:00 CST 2015, time=2015-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570947, encodeId=452515e0947c3, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Mon Feb 23 08:08:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16750, encodeId=56a616e50d6, content=文章好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Feb 23 01:05:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16705, encodeId=a8c816e051c, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:23:00 CST 2015, time=2015-02-22, status=1, ipAttribution=)]
    2015-02-22 orthoW

    不错的文章,学习了

    0

相关资讯

EJCB:抑制乳腺癌肿瘤细胞关键因子的揭示

一项由纽约爱因斯坦医学院的西班牙研究员何塞哈维尔•布拉沃 - 科尔德罗领导的新研究中,详细介绍了低表达前纤维蛋白-1的细胞如何在乳腺癌的肿瘤细胞中增加其转移并侵入其他组织的能力。 近年来,医学专家一直对开发新的治疗方法来对抗癌细胞的扩散非常感兴趣,癌细胞扩散也是癌症患者的最大的死亡原因。 然而,抑制或防止肿瘤细胞从原发肿瘤扩散的有效的治疗方法还没有被开发,其中关键一步就是肿瘤在转移过程中达到不

Breast J:广泛肿瘤成型术---需要乳房切除患者的保乳新方法

Extreme oncoplasty是一种乳腺癌保乳手术,使用oncoplastic技术,针对被大多数医生建议需要切除乳房的患者。这些患者通常具有大于等于5cm的多发性病灶或多中心癌肿。很多已经确定有淋巴结转移。大多数乳癌患者需要放射治疗,甚至是乳房全切术。66例多灶性,多中心,或原发晚期肿瘤的病例作为本次研究的对象,其癌肿超过50mm(极端病例)。所有患者均接受了切除和oncoplastic重建

N Engl J Med:辅助卵巢抑制治疗在绝经前乳腺癌的应用研究

背景抑制卵巢雌激素分泌能够减少雌激素受体阳性的绝经前女性的早期乳腺癌的复发率,但是它的作用在加入泰莫西芬(三苯氧胺,雌激素拮抗药)后是不确定的。方法随机地分配3066个绝经前女性,根据优先接受和未接受化疗分组,接受5年的泰莫西芬治疗,其中泰莫西芬联合卵巢抑制,或者依西美坦联合卵巢抑制。主要分析验证泰莫西芬联合卵巢抑制以提升无病生存率的假设,与单纯使用泰莫西芬进行比较。在总体分析中,46.7%的病人

微波热声医疗平台可检测早期乳腺癌

近日,由中国科学院沈阳自动化研究所雷达系统研究与应用技术重点实验室研究开发的用于乳腺肿瘤早期检测的微波热声医疗平台取得新进展。 临床实践证明,早期发现的乳腺癌">乳腺癌(肿瘤直径<2cm)治愈率高达98%以上,因此发现一个早期乳腺癌对患者的意义远大于目前任何治疗方案。 乳腺肿瘤早期检测微波热声医疗平台克服了常规检测方法低分辨率、低对比度、存在电离辐射等问题,利用不同生物组织在微波激

NEJM:未绝经乳腺癌患者的内分泌治疗

对于绝经前早期乳癌女性患者,若病灶免疫组化结果提示雌激素受体阳性或孕激素受体阳性,临床上通常会行内分泌治疗——使用药物抑制卵巢功能,减少雌激素生产,从而减少乳癌复发,但是目前对于该类患者使用添加了他莫昔芬的抑制卵巢雌激素生成疗法的疗效并不明确。因此Prudence A等人进行了一项试验,以评估对进行了完整化疗后未绝经患者以及单独使用他莫昔芬的未绝经患者,行辅助内分泌治疗是否合适。研究的初始数据分析

JCO:早期乳腺癌化疗或增加白血病患病风险

美国研究报道称,早期乳腺癌行预防性化疗或辅助化疗后,罹患白血病的风险将增加,这也意味着额外的治疗并不一定能带来额外的生存获益。他们发现行辅助化疗或预防性化疗的早期乳腺癌患者 10 年罹患白血病累积风险为 0.5%,大约为之前研究报告的 2 倍。该报告的研究者是来自约翰霍普金斯大学医学院肿瘤学的荣誉教授 Judith Karp 博士,他在一份通讯稿中说,骨髓肿瘤如白血病的发病率低,这是毫无疑问的